(TMHC) Taylor Morn Home - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US87724P1066

TMHC: Homes, Communities, Properties, Financial Services

Taylor Morrison Home Corporation (TMHC) stands as a prominent public homebuilder in the U.S., with a rich history dating back to 1936. Headquartered in Scottsdale, Arizona, the company is known for its diverse portfolio, including single-family homes, multi-family units, and master-planned communities. Under brands like Taylor Morrison, Darling Homes Collection, and Esplanade, they operate across key states such as California, Texas, Florida, and others, showcasing their strategic market presence.

Financially, TMHC boasts a market cap of around $6.67 billion, with a P/E ratio of 8.54 and a forward P/E of 7.69, suggesting potential value for investors. The P/B ratio of 1.21 and P/S of 0.85 indicate moderate valuation, reflecting the industrys current landscape. Their financial services, including title insurance and closing solutions, add revenue streams and enhance customer retention through a one-stop approach.

Operational strategies highlight their focus on mixed-use developments under the Urban Form brand, diversifying beyond traditional homebuilding. This approach attracts investors seeking broader real estate exposure. Their emphasis on master-planned communities underscores long-term development commitments, potentially offering stability in a cyclical industry.

Geographic diversity across booming and cooling markets mitigates risk, exposing them to varied economic conditions. Factors like interest rates and land management are crucial, given the industrys cyclical nature. Recent initiatives in sustainability and technology integration could differentiate TMHC, aligning with modern consumer and investor expectations.

Investment considerations include evaluating TMHCs position within the cyclical homebuilding sector, their strategic land holdings, and operational efficiency. While the company offers diversification and potential value, investors should weigh these against industry risks and market conditions.

Additional Sources for TMHC Stock

TMHC Stock Overview

Market Cap in USD 5,910m
Sector Consumer Cyclical
Industry Residential Construction
GiC Sub-Industry Homebuilding
IPO / Inception 2013-04-10

TMHC Stock Ratings

Growth 5y 85.2%
Fundamental 31.6%
Dividend 0.0%
Rel. Strength Industry 11.5
Analysts 4.22/5
Fair Price Momentum 72.68 USD
Fair Price DCF 27.19 USD

TMHC Dividends

No Dividends Paid

TMHC Growth Ratios

Growth Correlation 3m -20.1%
Growth Correlation 12m 48.8%
Growth Correlation 5y 89.8%
CAGR 5y 49.84%
CAGR/Max DD 5y 1.22
Sharpe Ratio 12m -0.26
Alpha -9.73
Beta 1.43
Volatility 34.72%
Current Volume 1061.6k
Average Volume 20d 1243k
What is the price of TMHC stocks?
As of March 20, 2025, the stock is trading at USD 60.21 with a total of 1,061,602 shares traded.
Over the past week, the price has changed by +1.23%, over one month by -2.73%, over three months by +1.64% and over the past year by +4.24%.
Is Taylor Morn Home a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Taylor Morn Home is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 31.64 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TMHC as of March 2025 is 72.68. This means that TMHC is currently undervalued and has a potential upside of +20.71% (Margin of Safety).
Is TMHC a buy, sell or hold?
Taylor Morn Home has received a consensus analysts rating of 4.22. Therefor, it is recommend to buy TMHC.
  • Strong Buy: 3
  • Buy: 5
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0
What are the forecast for TMHC stock price target?
According to ValueRays Forecast Model, TMHC Taylor Morn Home will be worth about 82 in March 2026. The stock is currently trading at 60.21. This means that the stock has a potential upside of +36.16%.
Issuer Forecast Upside
Wallstreet Target Price 77.3 28.4%
Analysts Target Price 82.2 36.5%
ValueRay Target Price 82 36.2%